Bodybuilders undergo drastic changes to their bodies that can result in sudden cardiac death. (Real Sports Photos/Shutterstock)
In a nutshell
- Professional bodybuilders face a dramatically higher risk of sudden cardiac death, with rates more than 14 times greater than amateur competitors, particularly among those currently competing or in the Mr. Olympia “open” category.
- Cardiovascular issues like enlarged hearts and thickened heart walls were the leading cause of death, but the study also found elevated risks of kidney failure, drug overdose, and suicide, underscoring both physical and mental health concerns.
- The sport lacks adequate medical oversight and anti-doping enforcement, prompting researchers to call for routine health checks, stronger drug testing, and educational efforts to reduce preventable deaths in elite bodybuilding.
PADUA, Italy — Behind all that buff bravado, professional bodybuilders face a risk of sudden cardiac death more than 14 times higher than their amateur counterparts. A new international study tracked over 20,000 male bodybuilders across 16 years, uncovering a disturbing pattern of premature deaths that raises serious questions about the safety of competitive bodybuilding at elite levels.
“While striving for physical excellence is admirable, the pursuit of extreme body transformation at any cost can carry significant health risks, particularly for the heart,” says lead author Dr. Marco Vecchiato from the University of Padova in Italy, in a statement.
For anyone who has followed bodybuilding competitions or fitness influencers on social media, the headlines about the sudden deaths of seemingly healthy, muscular athletes have become increasingly common. Now, for the first time, research published in the European Heart Journal gives hard data on just how dangerous the pursuit of extreme muscle development can be.
Startling Death Rates Among Elite Competitors
To calculate risk over time, researchers used a measure called “athlete-years,” which accounts for both the number of athletes in the study and how long each was tracked. For example, following 100 athletes for one year equals 100 athlete-years.

Professional bodybuilders in the study died at a rate of 317.56 deaths per 100,000 athlete-years, far exceeding mortality rates seen in other elite sports. Even more alarming, the incidence of sudden cardiac death (SCD) among currently competing professionals reached nearly 130 cases per 100,000 athlete-years.
For currently competing professional bodybuilders (those who participated in at least one competition within the previous year), the all-cause mortality rate was 208.06 per 100,000 athlete-years.
The risk proved especially high for competitors in the prestigious Mr. Olympia “open” category, where 7% of athletes died during the study period, including 5% from sudden cardiac death at an average age of just 36 years old.
According to the research team, high-level professional athletes face increased health complications due to extreme training regimens, stringent dietary restrictions, and frequent performance-enhancing drug use compared to amateur athletes.
The study identified 121 deaths among 20,286 male bodybuilders who competed in International Federation of Bodybuilding and Fitness (IFBB) events between 2005 and 2020. Researchers followed these athletes for an average of 8.1 years, creating a dataset covering 190,211 athlete-years.
Sudden cardiac death emerged as the leading cause of mortality, accounting for 38% of all identified deaths. Available autopsy reports consistently showed cardiomegaly (enlarged heart) and ventricular hypertrophy (thickened heart muscle walls), conditions that can trigger life-threatening heart rhythms.
While many sports carry risks, bodybuilding appears uniquely dangerous. The research team noted that studies conducted over the past 30 years in young athletes and military personnel have shown variable incidence rates of sudden cardiac death, but all were far lower than what was observed in this bodybuilding sample.
Geographic differences emerged in the data, with most deceased athletes coming from North America (40.5%, primarily from the USA), followed by Europe (38.8%). Deaths were documented across all inhabited continents.
Other Causes of Concern
Beyond cardiac issues, the study found bodybuilders faced elevated risks of kidney-related deaths, with several athletes dying from kidney/multi-organ failure. Other causes included vehicle accidents, cancer, COVID-19 complications, murder/suicide, and drug overdoses.
Mental health concerns were also common. The researchers observed that body dysmorphic disorders combined with substance abuse create an environment that increases the risks of impulsive or self-destructive behaviors.

What makes bodybuilding so dangerous? While the study didn’t definitively answer this question, the researchers pointed to several potential factors, including performance-enhancing drug use. Anabolic-androgenic steroids (AAS) are estimated to be used by more than 75% of male competitive bodybuilders, according to previous research.
These substances can adversely affect the cardiovascular system, contributing to an increased risk of sudden cardiac death. They can lead to hypertension, ventricular hypertrophy, cardiomegaly, and systolic dysfunction.
The extreme practices surrounding competitions may also play a role. Bodybuilders often engage in drastic weight loss before events through severe caloric restriction and dehydration. Five athletes in the study died from sudden cardiac death during or shortly after an official competition.
Lack of Oversight and Testing Concerns
Despite these dangers, bodybuilding lacks the medical oversight common in other sports. Bodybuilding doesn’t typically involve specific medical risk assessment, and many countries don’t even classify it as a sport, which prevents professionals from receiving specific evaluations and medical checks.
The study also raised concerns about inadequate drug testing in competitive bodybuilding. According to the most recent available World Anti-Doping Agency (WADA) report, only 80 samples from IFBB competitions were submitted for doping analyses, resulting in a 13% positive rate. That is over fifty times higher than that reported by FIFA and about five times higher than that of the International Powerlifting Federation.
According to the researchers, these findings prompted WADA to approach the IFBB about its inadequate testing program and insufficient resources devoted to doping control.
The study authors called for collaboration between medical associations and the bodybuilding community to develop preventive strategies, including intensified doping control, regular medical checks, and educational initiatives.
“The research challenges the idea that appearance alone is an indicator of health and highlights the hidden risks that can exist behind even the most sculpted physiques,” adds Dr. Vecchiato. “However, our findings are not an indictment of strength training or the fitness culture in general. On the contrary, regular physical activity and strength training can be extremely beneficial for health, quality of life, and mortality risk.”
There is a stark difference in risk between casual gym-goers and elite bodybuilders who push their bodies to extreme limits. The researchers found that classic physique competitors, who face weight-height limits that discourage extreme muscle mass, had a risk of sudden cardiac death five times lower than those in the unlimited “men’s bodybuilding” division.
This is a wake-up call for a sport that has long operated with minimal medical oversight despite mounting evidence of health risks. These alarming death rates point to an urgent need for improved preventive measures to promote safer participation in the sport.
Paper Summary
Methodology
Researchers conducted a retrospective observational study of 20,286 male athletes who participated in International Federation of Bodybuilding and Fitness (IFBB) competitions between 2005 and 2020. They classified athletes by age (junior, open, master), division (men’s bodybuilding or classic physique), and level (professional or amateur). To identify deaths, researchers performed standardized web searches using specific keywords related to “death” in five languages, examining official media reports, social media platforms, and specific forums/blogs. They verified each case and categorized deaths as sudden death (SD) or non-sudden death, with sudden deaths further classified as traumatic or non-traumatic, the latter including sudden cardiac deaths (SCD). The average follow-up period was 8.1 years, totaling 190,211 athlete-years of surveillance.
Results
During the study period, 121 deaths were identified at a mean athlete age of 45.3 years. Of these, 73 were classified as sudden deaths, with 46 categorized as sudden cardiac deaths occurring at an average age of 42.2 years. The overall incidence of death was 63.61 per 100,000 athlete-years, while the SCD rate was 24.18 per 100,000 athlete-years. Professional bodybuilders had a mortality risk 5.23 times higher than amateurs, with their SCD incidence reaching 193.63 per 100,000 athlete-years – over 14 times higher than amateurs. Currently competing athletes (those who participated in at least one competition within the previous year) showed an even higher incidence of SCD at 32.83 per 100,000 athlete-years. Among Mr. Olympia “open” category competitors, 7% died during the study period, including 5% from SCD at a mean age of just 36 years.
Limitations
The researchers acknowledged several limitations. The web-search methodology, while systematic, cannot match the precision of prospective death registries. Limited autopsy findings were available (only for about 10% of SCD cases), and many diagnoses were derived from clinical interpretation of online reports. The analysis was time-limited by research methodology, and amateur and master athletes with limited notoriety may be underrepresented. Athletes were considered as competing only if they participated in an IFBB competition within the previous year, while potential participation in other federations’ events could not be excluded. The web-based search was conducted in only five languages, potentially missing information reported exclusively in other languages.
Funding/Disclosures
All authors declared no funding for this contribution and no conflicts of interest.
Publication Information
The study titled “Mortality in male bodybuilding athletes” was conducted by researchers from the University of Padova, Italy, along with collaborators from other institutions. It was published in the European Heart Journal on May 21, 2025. The lead author was Marco Vecchiato, and the corresponding author was Andrea Ermolao from the Sports and Exercise Medicine Division, Department of Medicine, University of Padova.







